A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

NCT05482971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Bleeding In Thrombocytopenia Explained

NCT03505086 ·Status: RECRUITING

Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia

NCT01998828 ·Status: TERMINATED ·Phase: PHASE2

Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.

NCT01791101 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

NCT02402998 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

NCT04518475 ·Status: RECRUITING ·Phase: PHASE4

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

NCT04539678 ·Status: COMPLETED

A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients

NCT03187652 ·Status: RECRUITING

hATG+CsA vs hATG+CsA+Eltrombopag for SAA

NCT02099747 ·Status: COMPLETED ·Phase: PHASE3

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

NCT02298075 ·Status: COMPLETED

The Prospective Randomized Controlled Study of Eltrombopag on Hematopoietic Reconstruction After Allogeneic HSCT

NCT03902041 ·Status: UNKNOWN

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

NCT02323178 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

NCT05438875 ·Status: COMPLETED ·Phase: PHASE3

Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT

NCT01286675 ·Status: COMPLETED ·Phase: EARLY_PHASE1

LENS - Long-term Eltrombopag Observational Study

NCT00643929 ·Status: COMPLETED

Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia

NCT07182760 ·Status: NOT_YET_RECRUITING

Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera

NCT01243073 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease

NCT01133860 ·Status: COMPLETED ·Phase: PHASE2

A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera

NCT01901432 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07231952 ·Status: RECRUITING ·Phase: PHASE2

A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP

NCT03524612 ·Status: COMPLETED ·Phase: PHASE2

Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study

NCT06991894 ·Status: COMPLETED

Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera

NCT01038856 ·Status: TERMINATED ·Phase: PHASE2

Biologic Characterization of Patients With ITP

NCT05694325 ·Status: RECRUITING ·Phase: NA

Eltrombopag for Inherited Thrombocytopenias

NCT02422394 ·Status: COMPLETED ·Phase: PHASE2